Knight Capital Group’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Knight Capital Group’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$23K	Buy	+11,897	New	+$23.9K	﹤0.01%	3163

Other funds holding CORV

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Knight Capital Group's CORV Position: Q2 2013 in Review

Knight Capital Group opened a new position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2013: 11,897 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #3163 among its holdings.

17 funds tracked by Wall St. Rank hold CORV as of Q2 2013.

Knight Capital Group held 11,897 shares of Correvio Pharma Corp. Ordinary Shares (Canada) worth $23K as of Q2 2013.
Correvio Pharma Corp. Ordinary Shares (Canada) was a new Knight Capital Group position in Q2 2013.
Correvio Pharma Corp. Ordinary Shares (Canada) made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3163 holding.
17 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.